Milestone Pharmaceuticals Inc (MIST) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Milestone Pharmaceuticals Inc   (NASDAQ: MIST)
 

Milestone Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Milestone Pharmaceuticals Inc inventory turnover ratio, the Milestone Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.03 in the second quarter 2026, MIST's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Milestone Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 12167 days, compare to 18250 days, in the Mar 31 2026 quarter.

Within Healthcare sector Milestone Pharmaceuticals Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

MIST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Milestone Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?




MIST Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.03 0.02 - - -
MIST's Total Ranking # # # # #
Average inventory processing period 14275 16125 - - -
Seq. Inventory Growth 158.6 % 181.79 % - - -
Seq. Cost of Sales Growth 128.57 % - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Milestone Pharmaceuticals Inc 's Inventories $ 5 Millions Visit MIST's Balance sheet
Milestone Pharmaceuticals Inc 's Cost of Revenues TTM $ 0 Millions Visit MIST's Income Statement
What are MIST's Sales? Visit MIST's Sales by Segment

Other Inventory Turnover Ratios
Milestone Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MIST's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MIST's Competitors
Inventory Turnover Ratio for MIST's Suppliers
Inventory Turnover Ratio for MIST's Customers

You may also want to know
MIST's Sales Growth Rates MIST's Pe Price to earnings ratio MIST's Receivables Turnover Ratio MIST's Stock Quote
MIST's Net Income Growth Rates MIST's Ps Price to Sales ratio MIST's Sales per Employee MIST's Asset Turnover Ratio
MIST's Net Margin MIST's Pb Price to Book ratio MIST's Financial Strength Ratios MIST's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Sarepta Therapeutics Inc   0.01 $ 11.600  Millions$ 974  Millions

Date modified: 2026-09-04T10:29:50+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.